×
American Well EBITDA 2019-2025 | AMWL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
American Well ebitda from 2019 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
American Well EBITDA 2019-2025 | AMWL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
American Well ebitda from 2019 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$46.1B
Hims & Hers Health (HIMS)
$11.6B
Doximity (DOCS)
$11.6B
Tempus AI (TEM)
$10B
IRhythm Technologies (IRTC)
$4.4B
Inspire Medical Systems (INSP)
$3.8B
Hinge Health (HNGE)
$3.7B
Privia Health (PRVA)
$2.5B
Enovis (ENOV)
$1.8B
Phreesia (PHR)
$1.6B
Schrodinger (SDGR)
$1.6B
10x Genomics (TXG)
$1.5B
Clover Health Investments (CLOV)
$1.5B
Azenta (AZTA)
$1.5B
Evolent Health (EVH)
$1.3B
Omnicell (OMCL)
$1.3B
Claritev (CTEV)
$763M
Fulgent Genetics (FLGT)
$582M
Veradigm (MDRX)
$547M
Standard BioTools (LAB)
$475M
Butterfly Network (BFLY)
$450M
Talkspace (TALK)
$430M
Outset Medical (OM)
$333M
TruBridge (TBRG)
$329M
Health Catalyst (HCAT)
$269M
Nyxoah SA (NYXH)
$267M
SOPHiA GENETICS SA (SOPH)
$231M
CapsoVision (CV)
$203M
KORU Medical Systems (KRMD)
$149M
Zepp Health (ZEPP)
$139M